Antiretroviral treatment in resource-poor settings: clinical research priorities

被引：36

作者：

Rabkin, M ^{[1
]}

El-Sadr, W

Katzenstein, DA

Mukherjee, J

Masur, H

Mugyenyi, P

Munderi, P

Darbyshire, J

机构：

[1] Columbia Univ, Dept Med, New York, NY 10027 USA

[2] Columbia Univ, Harlem Hosp, Mailman Sch Publ Hlth, New York, NY USA

[3] Columbia Univ, Harlem Hosp, Div Infect Dis, New York, NY USA

[4] Stanford Univ, Dept Med, Stanford, CA 94305 USA

[5] Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA

[6] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA

[7] Joint Clin Res Ctr, Kampala, Uganda

[8] WHO, Dept Essential Drugs & Med, CH-1211 Geneva, Switzerland

[9] Med Res Ctr, Clin Trials Unit, London, England

来源：

LANCET | 2002年 / 360卷 / 9344期

关键词：

D O I：

10.1016/S0140-6736(02)11478-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1503 / 1505

页数：3

共 26 条

[1] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].

Bangsberg, DR ;

Hecht, FM ;

Charlebois, ED ;

Zolopa, AR ;

Holodniy, M ;

Sheiner, L ;

Bamberger, JD ;

Chesney, MA ;

Moss, A .

AIDS, 2000, 14 (04) :357-366

[2] Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].

Bangsberg, DR ;

Perry, S ;

Charlebois, ED ;

Clark, RA ;

Roberston, M ;

Zolopa, AR ;

Moss, A .

AIDS, 2001, 15 (09) :1181-1183

[3]

BEDELL R, 2001, 1 IAS C HIV PATH TRE

[4] Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].

Cameron, DW ;

Heath-Chiozzi, M ;

Danner, S ;

Cohen, C ;

Kravcik, S ;

Maurath, C ;

Sun, E ;

Henry, D ;

Rode, R ;

Potthoff, A ;

Leonard, J .

LANCET, 1998, 351 (9102) :543-549

[5]

CHAPMAN K, 2001, UNAIDS0193E

[6] Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia [J].

Deeks, SG ;

Barbour, JD ;

Grant, RM ;

Martin, JN .

AIDS, 2002, 16 (02) :201-207

[7] Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy [J].

Descamps, D ;

Flandre, P ;

Calvez, V ;

Peytavin, G ;

Meiffredy, V ;

Collin, G ;

Delaugerre, C ;

Robert-Delmas, S ;

Bazin, B ;

Aboulker, JP ;

Pialoux, G ;

Raffi, F ;

Brun-Vézinet, F .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :205-211

[8]

DIDER JM, 2001, J ACQ IMMUN DEF SYND, V26, P193

[9] Community-based approaches to HIV treatment in resource-poor settings [J].

Farmer, P ;

Léandre, F ;

Mukherjee, JS ;

Claude, MS ;

Nevil, P ;

Smith-Fawzi, MC ;

Koenig, SP ;

Castro, A ;

Becerra, MC ;

Sachs, J ;

Attaran, A ;

Kim, JY .

LANCET, 2001, 358 (9279) :404-409

[10] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Richman, DD ;

Valentine, FT ;

Jonas, L ;

Meibohm, A ;

Emini, EA ;

Chodakewitz, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739

← 1 2 3 →